Ascendis Pharma A/S ADR (ASND)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

TUBORG BOULEVARD 12 HELLERUP, DENMARK DK-2900

Ascendis Pharma A/S manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes.

Data based on most recent fiscal year report
Market Cap2.155 Billion Shares Outstanding36.37 Million Avg Volume208.149 Thousand
1-Yr BETA vs S&P TR1.096 Current Ratio13.67 Quick Ratio13.67
View SEC Filings from ASND instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ASND now:
Filers who had this stock in their top 10: 15 10 (1.03%)
13F Filers holding this stock: 132 34 (3.51%)
Aggregate 13F shares on 06/30/2019: 47.639 Million 23.776 Million
Aggregate 13F shares on 03/31/2019: 46.016 Million 26.318 Million
Percent change: 3.53% -9.66%
Funds creating new positions: 19 5
Funds Adding to an existing position: 55 10
Funds closing out their position: 24 8
Funds reducing their position: 42 14
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding ASND (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments